CRONUS PHARMA LLC — Cefpodoxime Importer Profile
Pharmaceutical Importer · #2 buyer for Cefpodoxime · $2.6M import value · 54 shipments · UNITED STATES · DGFT Verified
CRONUS PHARMA LLC is the #2 importer of Cefpodoxime from India with $2.6M in import value and 54 verified shipments. CRONUS PHARMA LLC holds a 1.6% market share in Cefpodoxime imports based in UNITED STATES. The company sources from 1 verified supplier across 38 formulations shipped to 1 country. Overall, CRONUS PHARMA LLC imports 2 pharmaceutical products worth $5.5M across 2 therapeutic categories.
CRONUS PHARMA LLC — Cefpodoxime Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Cefpodoxime to CRONUS PHARMA LLC?
Verified from 54 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| AUROBINDO PHARMA LIMITED | $2.6M | 54 | 100.0% |
CRONUS PHARMA LLC sources Cefpodoxime from 1 verified Indian supplier based on 54 customs records. The primary supplier is AUROBINDO PHARMA LIMITED accounting for 100.0% of imports.
How Does CRONUS PHARMA LLC Compare to Nearest Cefpodoxime Importers?
Buyers ranked immediately above and below #2 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | ALKALOID AD SKOPJE | NORTH MACEDONIA | $2.6M | 68 | $38.1K |
| 8 | NORTHSTAR DISTRIBUTION CENTER 8912 | UNITED STATES | $2.0M | 60 | $32.8K |
| 2 | CRONUS PHARMA LLC ★ | UNITED STATES | $1.3M | 26 | $50.0K |
| 12 | CENTRE SPECIALITIES PHARMACEUTIQUES | FRANCE | $1.2M | 34 | $35.3K |
| 3 | CRONUS PHARMA LLC, ★ | UNITED STATES | $1.1M | 21 | $50.0K |
CRONUS PHARMA LLC ranks #2 among 442 Cefpodoxime importers from India. Average shipment value of $50.0K compared to the market average of $32.3K. The closest competitors by value are ALKALOID AD SKOPJE and NORTHSTAR DISTRIBUTION CENTER 8912.
Where Does CRONUS PHARMA LLC Import Cefpodoxime To?
Destination countries from 54 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.6M | 54 | 100.0% |
CRONUS PHARMA LLC imports Cefpodoxime to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $2.6M.
What Cefpodoxime Formulations Does CRONUS PHARMA LLC Import?
| Formulation | Value | Shipments |
|---|---|---|
| CEFPODOXIME PROXETIL TABLETS 200MG (Cefp | $150.0K | 3 |
| CEFPODOXIME PROXETIL TABLETS 200MG (CEFPODOXIME PROXETIL TABLETS, USP 200MG) (6706 PACK) | $150.0K | 3 |
| CEFPODOXIME PROXETIL TABLETS 200MG (CEFPODOXIME PROXETIL TABLETS, USP 200MG) (6730 PACK) | $150.0K | 3 |
| CEFPODOXIME PROXETIL TABLETS 200MG ( CEFPODOXIME PROXETIL TABLETS USP 200 MG ) | $133.0K | 3 |
| CEFPODOXIME PROXETIL TABLETS USP 200MG (3383 X 100'S PACK) | $131.3K | 3 |
| CEFPODOXIME PROXETIL TABLETS 100MG (CEFPODOXIME PROXETIL TABLETS, USP 100MG) (6646 PACK) | $110.8K | 3 |
| CEFPODOXIME PROXETIL TABLETS USP 100MG ( | $100.0K | 2 |
| CEFPODOXIME PROXETIL TABLETS USP 200 MG | $100.0K | 2 |
| CEFPODOXIME PROXETIL TABLETS USP 200MG | $100.0K | 2 |
| CEFPODOXIME PROXETIL TABLETS 200MG CEFPODOXIME PROXETIL TABLETS USP 200 MG | $84.3K | 2 |
CRONUS PHARMA LLC imports 38 distinct Cefpodoxime formulations from India. The top formulation is CEFPODOXIME PROXETIL TABLETS 200MG (Cefp with 3 shipments worth $150.0K.
Regulatory Requirements: Importing Cefpodoxime into United States
What CRONUS PHARMA LLC and other importers must comply with to import Cefpodoxime from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Cefpodoxime
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Cefpodoxime from India and How Much Does CRONUS PHARMA LLC Import?
India exported $14.3M worth of Cefpodoxime through 1,734 shipments from 178 suppliers to 78 countries, serving 442 buyers globally. CRONUS PHARMA LLC imports $2.6M of this total, accounting for 1.6% of India's Cefpodoxime exports with 54 shipments from UNITED STATES. This is verified from 54 customs shipment records covering 38 distinct formulations.
What Is the Average Order Value for CRONUS PHARMA LLC's Cefpodoxime Imports?
CRONUS PHARMA LLC's average Cefpodoxime order value is $48.2K per consignment, based on 54 shipments totaling $2.6M. CRONUS PHARMA LLC is based in UNITED STATES and ranks #2 among all Cefpodoxime importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Cefpodoxime to CRONUS PHARMA LLC?
CRONUS PHARMA LLC sources Cefpodoxime from 1 verified Indian supplier: AUROBINDO PHARMA LIMITED ($2.6M, 100.0%). This is based on 54 customs records.
How Does CRONUS PHARMA LLC Compare to Other Cefpodoxime Importers?
CRONUS PHARMA LLC ranks #2 among 442 Cefpodoxime importers from India with a 1.6% market share. The top 3 importers are ALKALOID AD SKOPJE ($2.6M), NORTHSTAR DISTRIBUTION CENTER 8912 ($2.0M), CRONUS PHARMA LLC ($1.3M). CRONUS PHARMA LLC processed 54 shipments from UNITED STATES.
About CRONUS PHARMA LLC
CRONUS PHARMA LLC imports 2 products worth $5.5M. Beyond Cefpodoxime, top products include Cephalexin. View the complete CRONUS PHARMA LLC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cefpodoxime — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cefpodoxime shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CRONUS PHARMA LLC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CRONUS PHARMA LLC's capped import value divided by total capped export value for Cefpodoxime across all Indian exporters.
- 5.Verified Records: This page is backed by 54 individual customs records matching CRONUS PHARMA LLC importing Cefpodoxime, covering 38 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 78+ countries, 442+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cefpodoxime Import Data for CRONUS PHARMA LLC
Access order-level details, pricing data, supplier connections, and competitive analysis for CRONUS PHARMA LLC's Cefpodoxime imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CRONUS PHARMA LLC
Full Company Profile →
2 products · $5.5M total trade · 2 categories
CRONUS PHARMA LLC × Cefpodoxime
Verified from customs records
Company Overview
Top Products by CRONUS PHARMA LLC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CRONUS PHARMA LLC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cefpodoxime. For current order-level data, contact TransData Nexus.